We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 6,613 results
  1. Non-canonical deubiquitination of OTUB1 induces IFNγ-mediated cell cycle arrest via regulation of p27 stability

    The deubiquitinase OTUB1, implicated as a potential oncogene in various tumors, lacks clarity in its regulatory mechanism in tumor progression. Our...

    Seul Gi Lee, Seon Min Woo, ... Taeg Kyu Kwon in Oncogene
    Article Open access 25 April 2024
  2. Inability to phosphorylate Y88 of p27Kip1 enforces reduced p27 protein levels and accelerates leukemia progression

    The cyclin-dependent kinase (CDK) inhibitor p27 Kip1 regulates cell proliferation. Phosphorylation of tyrosine residue 88 (Y88) converts the inhibitor...

    Heidelinde Jäkel, Martin Taschler, ... Ludger Hengst in Leukemia
    Article Open access 21 May 2022
  3. Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway

    Background

    Although the serrated-neoplasia pathway reportedly accounts for 15–30% of colorectal cancer (CRC), no studies on chemoprevention of sessile...

    Tomoyuki Kawaguchi, Koichi Okamoto, ... Tetsuji Takayama in Journal of Gastroenterology
    Article 22 November 2023
  4. Assessment of survivin and p27 expression as potential prognostic markers in urothelial cell carcinoma of urinary bladder in Egyptian patients

    Background

    Bladder cancer (BC) is the tenth most common cancer worldwide with urothelial carcinoma (UC) being the main histologic subtype. Survivin is...

    Noha Said Helal, Zeinab Omran, Mona Moussa in African Journal of Urology
    Article Open access 16 September 2022
  5. A Genetic and Immunohistochemical Analysis of Helicobacter pylori Phenotypes and p27 Expression in Adenocarcinoma Patients in Jordan

    Stomach (gastric) cancer is one of the most prevalent and deadly cancers worldwide and most gastric cancers are adenocarcinomas. Based on prior...

    Suhaila A. Al-Sheboul, Ahmad Abdul-Razzak Mohammad, ... Ismail I. Matalka in Journal of Epidemiology and Global Health
    Article Open access 18 April 2023
  6. SUV39H1 regulates corneal epithelial wound healing via H3K9me3-mediated repression of p27

    Background

    Corneal epithelial wound healing (CEWH) is vital for maintaining the integrity and barrier function of the cornea. Although histone...

    Shuai Yang, Weiwei Chen, ... Dongsheng Yan in Eye and Vision
    Article Open access 01 February 2022
  7. KIF14 affects cell cycle arrest and cell viability in cervical cancer by regulating the p27Kip1 pathway

    Background

    Cervical cancer is a kind of malignant gynecological tumor. The first choice for treating cervical cancer is still a combination of surgery...

    Jie Zhang, Gulimire Buranjiang, ... Liyan Yao in World Journal of Surgical Oncology
    Article Open access 19 April 2022
  8. Decreased cell proliferation and induced apoptosis in human B-chronic lymphocytic leukemia following miR-221 inhibition through modulation of p27 expression

    Background

    This study aimed to investigate the effects of the miR-221 inhibition on the human B-chronic lymphocytic leukemia (B-CLL) cell viability...

    Korosh Ashrafi Dehkordi, Majid Asadi-Samani, ... Mohammad-Reza Mahmoudian-Sani in Egyptian Journal of Medical Human Genetics
    Article Open access 26 August 2022
  9. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1

    Cervical cancer is one of the most common types of female cancers worldwide. IL-29 is an interesting cytokine in the IFNλ family. Its role in the...

    Jackie L. Ha, Erin Kaser, ... Yujiang Fang in Medical Oncology
    Article 28 January 2024
  10. MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway

    Purpose

    Increasing evidences suggest dysfunctions of microRNAs (miRNAs) are playing important part in tumors. Therefore, the role of miR-802 in...

    L. F. Gao, S. Jia, ... Y. H. Li in Clinical and Translational Oncology
    Article 27 July 2021
  11. Expression of p27 and p16 and their clinical significance in gastric cancer

    Background

    Deregulated expression of cell cycle regulators p27 and p16 is associated with cancer progression. p27 kip1 and p16 INKa are a cyclin...

    S. Kumari, P. Kumar, ... G. Narayan in Clinical and Translational Oncology
    Article 02 September 2020
  12. UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development

    Genomic sequencing analysis of tumors provides potential molecular therapeutic targets for precision medicine. However, identifying a key driver gene...

    Ren-Yu Zhang, Ze-Kun Liu, ... Huijie Bian in Signal Transduction and Targeted Therapy
    Article Open access 16 February 2021
  13. Significance of p53, p27, Ki-67, E-cadherin, and HER2 expression in upper urinary tract urothelial carcinoma

    Background

    The study investigated the expression and the clinicopathological significance of p53, p27, Ki-67, E-cadherin, and HER2 in upper urinary...

    Nabiha Missaoui, Ahlem Bdioui, ... Sihem Hmissa in Journal of the Egyptian National Cancer Institute
    Article Open access 15 September 2020
  14. Clinical significance of p27 Kip1 expression in advanced ovarian cancer

    Background

    Ovarian cancer is the most common gynecological malignancy. In patients with advanced ovarian cancer, some biological parameters have...

    Amani A. Alrehaili, Majed AlMourgi, ... Nermin Raafat in Applied Cancer Research
    Article Open access 03 June 2020
  15. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors

    Primary hyperparathyroidism with parathyroid tumors is a typical manifestation of Multiple Endocrine Neoplasia Type 1 (MEN1) and is historically...

    Konstantin Bräutigam, Cédric Nesti, ... Reto M. Kaderli in Virchows Archiv
    Article Open access 20 January 2024
  16. Inhibitory Effect of PPARδ Agonist GW501516 on Proliferation of Hypoxia-induced Pulmonary Arterial Smooth Muscle Cells by Regulating the mTOR Pathway

    Objective

    This study aimed to investigate the effects of the peroxisome proliferator-activated receptor δ (PPARδ) agonist GW501516 on the...

    Chang-gui Chen, Chun-feng Yi, ... Li-qun He in Current Medical Science
    Article 22 August 2023
  17. A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27

    Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related mortality in the United States. Exploring the mechanism of HCC and...

    Dehai Wu, Yan Wang, ... Lianxin Liu in Oncogene
    Article Open access 18 August 2020
  18. TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer

    MET amplification/mutations are important targetable oncogenic drivers in NSCLC, however, acquired resistance is inevitable and the majority of...

    Vinod Kumar, Zachary A. Yochum, ... Timothy F. Burns in Oncogene
    Article Open access 01 March 2024
  19. LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas

    Mutants in the gene encoding mitochondrion-associated protein LRPPRC were found to be associated with French Canadian Type Leigh syndrome, a human...

    Wenjiao Li, Yuan Dai, ... Leyuan Liu in Oncogene
    Article 16 March 2020
  20. Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma

    Osteosarcoma(OS) is a highly aggressive bone cancer for which treatment has remained essentially unchanged for decades. Although OS is characterized...

    Jichuan Wang, Alexander Ferrena, ... Bang H. Hoang in Oncogene
    Article Open access 14 February 2024
Did you find what you were looking for? Share feedback.